Personalized medicine with biologics for severe type 2 asthma: current status and future prospects

  • Marie Godar, Christophe Blanchetot, Hans de Haard, Bart N. Lambrecht, Guy Brusselle
  • mAbs, November 2017, Taylor & Francis
  • DOI: 10.1080/19420862.2017.1392425

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/19420862.2017.1392425